IL9 and cancer: Given the strong effector functions harboured by TH9 cells, we believe that the identification of autophagy as a factor dictating IL-9 secretion from TH9 cells provides significant insights to design new therapies not only against cancer but also to alleviate the course of allergic and autoimmune diseases.